Kenya recalls Benylin cough syrup over safety concerns
Health & Science
By
Winfrey Owino
| Apr 11, 2024
The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.
Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.
In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.
The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.
READ MORE
World Bank approves Sh71 billion for Isiolo-Mandera road construction
Banks double lending target to small businesses to hit Sh326b
Contradictions in rural economies 13 years into devolved governance
Return of the bitter pill: Kenya softens IMF stance as Iran shock bites
Court clears way for Sh619 billion EABL shares sale
JKUAT to assemble 3,000 computers for digital hubs countrywide
Jubilee Holdings profit jumps 18 per cent on increased revenue
Why data privacy matters for Kenyan enterprises
African electric vehicle firm bets on innovation with US stock listing
How green certification is driving regional demand for warehouses